Molecular marker for detecting susceptibility of ovarian cancer
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANDONG UNIV QILU HOSPITAL
- Publication Date
- 2014-04-16
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a molecular marker, a kit and a detection method for detecting the susceptibility of ovarian cancer, in particular to the single nucleotide polymorphism (single nucleotide polymorphism, SNP) of GADD45A gene and its correlation with ovarian cancer The properties, and methods and kits for detecting these SNPs belong to the fields of molecular biology and medicine. Background technique
[0002] Ovarian cancer is the most lethal tumor of the female reproductive system. In 2008, there were 225,500 new cases and 140,200 deaths worldwide. Due to insidious onset and inconspicuous symptoms, most patients are diagnosed at an advanced stage. The 5-year survival rate of patients with advanced ovarian cancer is only about 30-45%, and the prognosis is poor. However, the 5-year survival rate of patients with early ovarian cancer is as high as 90%. It reminds us that the key to improving the prognosis and survival of ovarian cancer pa...